Companion Diagnostics: From Biomarker Identification to Market Entry
7 World Trade Center
250 Greenwich Street
New York, NY USA
Companion Diagnostics: From Biomarker Identification to Market Entry
New York Academy of Sciences
7 World Trade Center
250 Greenwich Street
New York

Schedule of Presentations:

Monday, April 28, 2014
07:00:00 Day 1 Concludes
07:15:00 Registration and Continental Breakfast
08:00:00 Welcome Remarks
08:05:00 Towards Biomarker-based Personalized Healthcare: Current Status and Future Trends Mikael Dolsten
08:05:00 Keynote Panel
08:15:00 Promoting Personalized Medicine through Policy Strategies Christopher P. Austin
08:25:00 Regulatory Strategies to Safely Accelerate the Implementation of Companion Diagnostics
08:35:00 Integrating Companion Diagnostics in the Healthcare — the Insurance Sector Perspective Michael Kolodziej
08:45:00 The Future of Academic Research towards Translation for Personalized Medicine Charles L Sawyers
08:55:00 Interactive Panel Discussion
09:40:00 Audience Q&A
10:00:00 Coffee Break
10:30:00 Introduction & Opening Remarks
10:55:00 Genomics Medicine Raju Kucherlapati
11:20:00 Functional Proteomics, Companion Diagnostics and Precise Medicine Peter Parker
11:45:00 Insights for Personalized Medicine from the Gut Microbiome Dusko Ehrlich
12:10:00 Networking Lunch
13:20:00 Case Study: Xalkori Companion Diagnostic Hakan Sakul
13:40:00 Industry Spotlight — Development of Selzentry (Maraviroc) and the Companion Diagnostic HIV Tropism Assay Charles Knirsch
14:00:00 Industry Spotlight — Development of Kalydeco as a Genotype Specific Drug for the Treatment of Cystic Fibrosis Federico Goodsaid
14:20:00 Industry Spotlight — Pathways of Disease Progression in Heart Failure: What Can Galectin-3 Tell Us?
15:10:00 Coffee Break
15:40:00 Biomarkers for Precision Medicine in Airway Diseases
15:40:00 Panel Discussion
15:40:00 Cardiovascular Disease — Implications for Personalized Medicine Julie A. Johnson
15:40:00 The Genetics of Multiple Sclerosis — Implications for Personalized Medicine
16:00:00 Stratified Medicine in Autoimmune Diseases: Rheumatoid Arthritis Examples Iain McInnes
16:00:00 Biomarkers for Parkinson's Disease — Imaging Onset, Progression, and Effect of Treatment
16:00:00 Advances in Blood Pressure Genomics Mark J. Caulfield
16:20:00 Towards Personalized and Precision Medicine for Obesity and Diabetes
16:20:00 mTOR Signaling: a Central Pathway to the Pathogenesis of Multiple Inflammatory and Immune System Disorders — Implications for Personalized Medicine Andras Perl
16:20:00 Identification of Biomarkers for the Diagnosis, Prediction, and Progression of Alzheimer's Disease Michelle Mielke
16:40:00 Hot Topic: Speaker selected from submitted abstracts
16:40:00 Hot Topic: Speaker selected from submitted abstracts
16:40:00 Hot Topic: Speaker selected from submitted abstracts
17:00:00 Panel Discussion
17:00:00 Panel Discussion
17:00:00 Panel Discussion
17:30:00 Poster Session and Networking Reception
Tuesday, April 29, 2014
08:00:00 Continental Breakfast
08:45:00 Highlights —Therapeutic Target Areas beyond Cancer: Infection and Immunology, Metabolic and Cardiovascular Diseases, and Neurodegenerative Disease
09:40:00 Sequencing Approaches for Personalized Cancer Therapy Selection Daniela Starcevic
10:00:00 The Impact of Epigenetics on the Future of Personalized Medicine Jane Mellor
10:20:00 Innovation in Metabolomics to Improve Personalized Healthcare Massimo Loda
10:40:00 Coffee Break
11:10:00 High Sensitivity Whole Blood Companion Diagnostics with T2MR Thomas Lowery
11:30:00 Harnessing Complex Biological Data for Personalized Medicine Robert M. Plenge
11:50:00 Panel Discussion
12:10:00 Networking Lunch
13:20:00 Biomarker Validation
13:40:00 Beyond Oncology — Future outlook for Companion Diagnostics-Challenges and Opportunities
14:00:00 Informatics Solutions for Biomarker Research and Personalized Medicine in Clinical Care
14:20:00 Regulatory Strategies to Accelerate Companion Diagnostics Development and Approval in the United States
14:40:00 Coffee Break
15:10:00 The European Union Regulatory Framework for Companion Diagnostics and Personalized Medicines in Comparison to US Legislation Angela Brand
15:30:00 Ways to Making Personalized Medicine more Affordable Naomi Aronson
15:50:00 Integrating Personalized Medicine into Clinical Practice and Preparing the Medical Provider Dan Roden
16:10:00 Panel Discussion
16:55:00 Closing Remarks
17:00:00 Adjourn
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.